• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例特发性肺纤维化患者的新型冠状病毒肺炎(COVID-19)致死病例

A Fatal Case of Coronavirus Disease 2019 (COVID-19) in a Patient With Idiopathic Pulmonary Fibrosis.

作者信息

Rajasurya Venkat, Gunasekaran Kulothungan, Damarla Vijay, Kolluru Anuradha

机构信息

Pulmonary Critical Care, Novant Health, Winston-Salem, USA.

Pulmonary Critical Care, Yale New Haven Health at Bridgeport Hospital, Bridgeport, USA.

出版信息

Cureus. 2020 Jun 3;12(6):e8432. doi: 10.7759/cureus.8432.

DOI:10.7759/cureus.8432
PMID:32642347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7336650/
Abstract

The number of cases of coronavirus disease 2019 (COVID-19) has been exponentially increasing everyday. It is important to recognize the comorbidities and risk factors associated with this highly contagious and serious disease that has caused thousands of deaths worldwide. Patients with certain conditions like diabetes, hypertension, cardiovascular disease and chronic lung diseases have been reported to develop serious complications from COVID-19. Idiopathic pulmonary fibrosis (IPF) is a disease that is more prevalent in the elderly population, the same group that are more susceptible to serious complications from COVID-19. Our literature search did not reveal any review about COVID-19 in IPF patients. We report a patient with IPF who was exposed to COVID-19 from her spouse and died from its complications. This case would help to raise the awareness among IPF patients to follow the necessary precautions to reduce the risk of contracting the disease.

摘要

2019年冠状病毒病(COVID-19)的病例数每天都在呈指数级增长。认识到与这种具有高度传染性且严重的疾病相关的合并症和风险因素很重要,该疾病已在全球导致数千人死亡。据报道,患有糖尿病、高血压、心血管疾病和慢性肺病等特定疾病的患者会因COVID-19而出现严重并发症。特发性肺纤维化(IPF)是一种在老年人群中更普遍的疾病,而这一群体也更容易因COVID-19出现严重并发症。我们的文献检索未发现任何关于IPF患者中COVID-19的综述。我们报告了一名IPF患者,她从配偶那里感染了COVID-19并死于其并发症。该病例将有助于提高IPF患者对采取必要预防措施以降低感染该疾病风险的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/7336650/fd20c558989a/cureus-0012-00000008432-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/7336650/fd20c558989a/cureus-0012-00000008432-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f5a/7336650/fd20c558989a/cureus-0012-00000008432-i01.jpg

相似文献

1
A Fatal Case of Coronavirus Disease 2019 (COVID-19) in a Patient With Idiopathic Pulmonary Fibrosis.一例特发性肺纤维化患者的新型冠状病毒肺炎(COVID-19)致死病例
Cureus. 2020 Jun 3;12(6):e8432. doi: 10.7759/cureus.8432.
2
COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review.COVID-19引发的特发性肺纤维化急性加重:一种诊断不足的具有双峰呼吸衰竭的临床实体——病例报告及文献综述
Front Med (Lausanne). 2022 Feb 3;9:815924. doi: 10.3389/fmed.2022.815924. eCollection 2022.
3
Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis.特发性肺纤维化患者感染 COVID-19 后临床结局较差:一项倾向评分匹配的多中心研究网络分析。
BMJ Open Respir Res. 2021 Aug;8(1). doi: 10.1136/bmjresp-2021-000969.
4
How does comorbidity influence survival in idiopathic pulmonary fibrosis?合并症如何影响特发性肺纤维化的生存率?
Respir Med. 2014 Apr;108(4):647-53. doi: 10.1016/j.rmed.2014.01.008. Epub 2014 Feb 2.
5
Serious adverse events in patients with idiopathic pulmonary fibrosis in the placebo arms of 6 clinical trials.6 项临床试验安慰剂组中特发性肺纤维化患者的严重不良事件。
Respir Med. 2019 Apr;150:120-125. doi: 10.1016/j.rmed.2019.02.021. Epub 2019 Mar 13.
6
COVID-19 Pneumonia and Idiopathic Pulmonary Fibrosis: A Novel Combination.新冠病毒肺炎与特发性肺纤维化:一种新的组合。
Turk Thorac J. 2020 Nov;21(6):451-453. doi: 10.5152/TurkThoracJ.2020.20123. Epub 2020 Nov 1.
7
The clinical impact of major comorbidities on idiopathic pulmonary fibrosis.主要合并症对特发性肺纤维化的临床影响。
Respir Investig. 2017 Mar;55(2):94-103. doi: 10.1016/j.resinv.2016.11.004. Epub 2017 Jan 14.
8
[Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry].[特发性肺纤维化的预后因素——捷克登记处分析]
Cas Lek Cesk. 2016;155(4):22-8.
9
[Radiotherapy of Lung Tumours in Idiopathic Pulmonary Fibrosis].[特发性肺纤维化中肺肿瘤的放射治疗]
Klin Onkol. 2017 Summer;30(4):303-306. doi: 10.14735/amko2017303.
10
Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.特发性肺纤维化以外的间质性肺疾病患者急性加重后的预后。
Clin Respir J. 2021 Mar;15(3):336-344. doi: 10.1111/crj.13304. Epub 2020 Dec 10.

引用本文的文献

1
Clinical impact of idiopathic pulmonary fibrosis on SARS-CoV-2 patient outcomes: a comprehensive analysis in the pre-vaccination era.特发性肺纤维化对感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)患者预后的临床影响:疫苗接种前时代的综合分析
Front Med (Lausanne). 2025 May 21;12:1567232. doi: 10.3389/fmed.2025.1567232. eCollection 2025.
2
Characteristics and outcomes of COVID-19 patients with IPF: A multi-center retrospective study.特发性肺纤维化合并 COVID-19 患者的特征和结局:一项多中心回顾性研究。
Respir Med Res. 2022 May;81:100900. doi: 10.1016/j.resmer.2022.100900. Epub 2022 Mar 3.
3
COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review.

本文引用的文献

1
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.2020 年 3 月 1 日至 30 日,14 个州住院的经实验室确诊的 2019 冠状病毒病患者的住院率和特征 - COVID-NET。
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3.
2
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病:考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
3
[Research advances in the mechanism of pulmonary fibrosis induced by coronavirus disease 2019 and the corresponding therapeutic measures].
COVID-19引发的特发性肺纤维化急性加重:一种诊断不足的具有双峰呼吸衰竭的临床实体——病例报告及文献综述
Front Med (Lausanne). 2022 Feb 3;9:815924. doi: 10.3389/fmed.2022.815924. eCollection 2022.
4
Angiotensin-Converting Enzyme 2 (ACE2), Transmembrane Peptidase Serine 2 (TMPRSS2), and Furin Expression Increases in the Lungs of Patients with Idiopathic Pulmonary Fibrosis (IPF) and Lymphangioleiomyomatosis (LAM): Implications for SARS-CoV-2 (COVID-19) Infections.血管紧张素转换酶2(ACE2)、跨膜丝氨酸蛋白酶2(TMPRSS2)和弗林蛋白酶在特发性肺纤维化(IPF)和淋巴管平滑肌瘤病(LAM)患者肺中的表达增加:对严重急性呼吸综合征冠状病毒2(SARS-CoV-2,即新冠病毒)感染的影响。
J Clin Med. 2022 Jan 31;11(3):777. doi: 10.3390/jcm11030777.
5
Stem cells part of the innate and adaptive immune systems as a therapeutic for Covid-19.作为治疗新冠肺炎的一种手段,干细胞是先天免疫系统和适应性免疫系统的一部分。
Commun Integr Biol. 2021 Sep 10;14(1):186-198. doi: 10.1080/19420889.2021.1965356. eCollection 2021.
6
Radiation-Induced Lung Injury-Current Perspectives and Management.辐射诱导的肺损伤——当前观点与管理
Clin Pract. 2021 Jul 1;11(3):410-429. doi: 10.3390/clinpract11030056.
7
Pulmonary fibrosis and its related factors in discharged patients with new corona virus pneumonia: a cohort study.出院的新型冠状病毒肺炎患者的肺纤维化及其相关因素:一项队列研究。
Respir Res. 2021 Jul 9;22(1):203. doi: 10.1186/s12931-021-01798-6.
8
COVID-19 Pneumonia and Idiopathic Pulmonary Fibrosis: A Novel Combination.新冠病毒肺炎与特发性肺纤维化:一种新的组合。
Turk Thorac J. 2020 Nov;21(6):451-453. doi: 10.5152/TurkThoracJ.2020.20123. Epub 2020 Nov 1.
9
Danhong injection in the treatment of idiopathic pulmonary fibrosis: A protocol for systematic review and meta-analysis.丹红注射液治疗特发性肺纤维化:一项系统评价与Meta分析方案
Medicine (Baltimore). 2020 Sep 11;99(37):e22016. doi: 10.1097/MD.0000000000022016.
10
Overwhelming COVID-19 Sepsis in a Patient With Idiopathic Pulmonary Fibrosis.一名特发性肺纤维化患者的重症新型冠状病毒肺炎脓毒症
Cureus. 2020 Jul 21;12(7):e9320. doi: 10.7759/cureus.9320.
[2019冠状病毒病所致肺纤维化机制及相应治疗措施的研究进展]
Zhonghua Shao Shang Za Zhi. 2020 Aug 20;36(8):691-697. doi: 10.3760/cma.j.cn501120-20200307-00132.
4
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
5
The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis.炎症在特发性肺纤维化发病机制中的作用。
Antioxid Redox Signal. 2008 Feb;10(2):287-301. doi: 10.1089/ars.2007.1897.